+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 20Years - 90Years
All Genders
ID06543082

Outcomes of Low-Dose Colchicine with Ticagrelor After Stent Placement in Acute Coronary Syndrome Patients A Phase 4 Study Evaluating Safety and Effectiveness Over 12 Months

Led by CHA University · Updated on 2026-02-18

490

Participants Needed

9

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying patients with acute coronary syndrome ACS who have undergone percutaneous coronary intervention PCI to evaluate the effects of a treatment combining ticagrelor P2Y12 inhibitor monotherapy with low-dose colchicine. This study aims to determine how often serious cardiovascular events and stent thrombosis occur within 12 months after PCI when aspirin is discontinued and replaced by colchicine alongside ticagrelor. The research will also compare this approach to different durations of dual antiplatelet therapy from previous studies to assess its effectiveness and safety. Participants will take low-dose colchicine 0.6 mg once daily with ticagrelor maintenance therapy 90 mg twice daily after PCI, stopping aspirin the day after the procedure. One month following PCI, a high-sensitivity C-reactive protein hs-CRP test will be conducted colchicine will be stopped if hs-CRP is below 2 mgL or continued for 12 months if it is 2 mgL or higher. Patients will have scheduled clinic visits at 1, 3, 6, 9, and 12 months post-PCI for follow-up. During the study, participants will undergo regular check-ups including hs-CRP testing and monitoring for cardiovascular events, stent thrombosis, bleeding, inflammation, platelet activity, and drug reactions to colchicine. Researchers will track these outcomes at multiple time points up to 12 months to assess the treatments clinical effects and safety. The total participation period spans one year after the PCI intervention.

CONDITIONS

Brief Title

MACT (Mono Antiplatelet and Colchicine Therapy) Prospective Multicenter Study

Research Team

H

Hwa-In Kim

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here